[1] |
Anseth KS,Klok HA.Click chemistry in biomaterials,nanomedicine,and drug delivery[J].Biomacromolecules,2016,17(1):1-3.
|
[2] |
Lai CH,Chang TC,Chuang YJ,et al.Stepwise orthogonal click chemistry toward fabrication of paclitaxel/galactose functionalized fluorescent nanoparticles for HepG2 cell targeting and delivery[J].Bioconjugate Chem,2013,24(10):1698-1709.
|
[3] |
Sun Q,Kang Z,Xue L,et al.A collaborative assembly strategy for tumor-targeted siRNA delivery[J].J Am Chem Soc,2015,137(18):6000-6010.
|
[4] |
Li N,Binder WH.Click-chemistry for nanoparticle-modification[J].J Mater Chem,2011,21(42):16717-16734.
|
[5] |
Na DH, DeLuca PP. PEGylation of octreotide: I. Separation of positional isomers and stability against acylation by poly(D,L-lactide-co-glycolide)[J].Pharm Res,2005,22(5):736-742.
|
[6] |
Na DH,Lee KC,DeLuca PP.PEGylation of octreotide:II.Effect of N-terminal mono-PEGylation on biological activity and pharmacokinetics[J].Pharm Res,2005,22(5):743-749.
|
[7] |
Blenke EO,Klaasse G,Merten H,et al.Liposome functionalization with copper-free “click chemistry”[J].J Control Release,2015,202:14-20.
|
[8] |
Dai W, Jin W, Zhang J, et al. Spatiotemporally controlled co-delivery of anti-vasculature agent and cytotoxic drug by octreotide-modified stealth liposomes[J].Pharm Res,2012,29(10):2902-2911.
|
[9] |
Zhang J,Jin W,Wang X,et al.A novel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin receptor 2 positive tumor models[J].Mol Pharmaceut,2010,7(4):1159-1168.
|
[10] |
Reynaert H,Rombouts K,Vandermonde A,et al.Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma[J].Gut,2004,53(8):1180-1189.
|
[11] |
Yuan D,Sun M,Wang Y,et al.Preparation and in vitro characterization of octreotide-targeting doxorubicin liposome[J].J China Pharm Univ(中国药科大学学报),2011,42(3):223-229.
|